European Leukemia Trial Registry
Trial: ASPIRE

More Details
Title Eltrombopag in Thrombocytopenic Subjects With MDS or AML
Scientific Title A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: Open-label, Part 2: Randomized, Double-blind, Part 3: Extension)
Short Title ASPIRE
Trialgroup NN
Type of Trial multicentric, randomized, prospective, double-blind
Disease Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.09.2011
Shortprotocol Shortprotocol
created 12.04.2013 Johannes Kraus
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org